These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23240035)

  • 1. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor.
    Yamamoto S; Ouchi Y; Nakatsuka D; Tahara T; Mizuno K; Tajima S; Onoe H; Yoshikawa E; Tsukada H; Iwase M; Yamaguti K; Kuratsune H; Watanabe Y
    PLoS One; 2012; 7(12):e51515. PubMed ID: 23240035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of reference tissue model of PET ligand [¹¹C]+3-MPB for the muscarinic cholinergic receptor in the living brain of conscious monkey.
    Yamamoto S; Ohba H; Nishiyama S; Takahashi K; Tsukada H
    Synapse; 2011 Jun; 65(6):548-51. PubMed ID: 21064187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
    Yamamoto S; Nishiyama S; Kawamata M; Ohba H; Wakuda T; Takei N; Tsukada H; Domino EF
    Neuropsychopharmacology; 2011 Jun; 36(7):1455-65. PubMed ID: 21430646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome.
    Tanaka S; Kuratsune H; Hidaka Y; Hakariya Y; Tatsumi KI; Takano T; Kanakura Y; Amino N
    Int J Mol Med; 2003 Aug; 12(2):225-30. PubMed ID: 12851722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
    Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
    Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
    Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
    Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.
    Loebel M; Grabowski P; Heidecke H; Bauer S; Hanitsch LG; Wittke K; Meisel C; Reinke P; Volk HD; Fluge Ø; Mella O; Scheibenbogen C
    Brain Behav Immun; 2016 Feb; 52():32-39. PubMed ID: 26399744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of muscarinic cholinergic receptor ligands N-[11C]ethyl-4-piperidyl benzilate and N-[11C]propyl-4-piperidyl benzilate: a PET study in comparison with N-[11C]methyl-4-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Sato K; Harada N; Kakiuchi T; Tsukada H
    Nucl Med Biol; 2000 Nov; 27(8):733-40. PubMed ID: 11150704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Structural Brain Networks Related to Adrenergic/Muscarinic Receptor Autoantibodies in Chronic Fatigue Syndrome.
    Fujii H; Sato W; Kimura Y; Matsuda H; Ota M; Maikusa N; Suzuki F; Amano K; Shin I; Yamamura T; Mori H; Sato N
    J Neuroimaging; 2020 Nov; 30(6):822-827. PubMed ID: 32609410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB.
    Yamamoto S; Maruyama S; Ito Y; Kawamata M; Nishiyama S; Ohba H; Yamada S; Tsukada H
    Neuroimage; 2011 Sep; 58(1):1-9. PubMed ID: 21712096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
    Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
    Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.
    Wirth K; Scheibenbogen C
    Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo visualization of central muscarinic receptors using [11C]quinuclidinyl benzilate and positron emission tomography in baboons.
    Varastet M; Brouillet E; Chavoix C; Prenant C; Crouzel C; Stulzaft O; Bottlaender M; Cayla J; Mazière B; Mazière M
    Eur J Pharmacol; 1992 Mar; 213(2):275-84. PubMed ID: 1521561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography.
    Shinotoh H; Asahina M; Inoue O; Suhara T; Hirayama K; Tateno Y
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):35-46. PubMed ID: 8579768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.
    Nakatomi Y; Mizuno K; Ishii A; Wada Y; Tanaka M; Tazawa S; Onoe K; Fukuda S; Kawabe J; Takahashi K; Kataoka Y; Shiomi S; Yamaguti K; Inaba M; Kuratsune H; Watanabe Y
    J Nucl Med; 2014 Jun; 55(6):945-50. PubMed ID: 24665088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and autoradiographic localization of muscarinic cholinergic antagonist (+)N-[11C]methyl-3-piperidyl benzilate as a potent radioligand for positron emission tomography.
    Takahashi K; Murakami M; Miura S; Iida H; Kanno I; Uemura K
    Appl Radiat Isot; 1999 Mar; 50(3):521-5. PubMed ID: 10070712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders.
    Klein R; Berg PA
    Eur J Med Res; 1995 Oct; 1(1):21-6. PubMed ID: 9392689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL; Lin JM; Reeves WC
    Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.